Periodontitis is a chronic inflammatory disease in the tissues and bones that support teeth. This condition is fairly common, affecting 10-15% adults worldwide. When untreated, the disease progresses deeper into the tissue, causing eventual loss of teeth. Ironically, patients have only few treatment options and mostly rely on uncomfortable dental procedures combined with antibiotics. GlycoMira is developing novel anti-inflammatory and anti-bacterial therapeutics to treat and prevent periodontitis. Please contact us for more information.